Transanal total mesorectal excision: how are we doing so far?-Reference-Cited by-同舟云学术

Transanal total mesorectal excision: how are we doing so far?

Published:2019-03-26 Issue:7 Volume:21 Page:767-774
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Dis

Author:

Sparreboom C. L.¹^ORCID,Komen N.²,Rizopoulos D.³,van Westreenen H. L.⁴,Doornebosch P. G.⁵,Dekker J. W. T.⁶,Menon A. G.⁵,Tuynman J. B.⁷,Daams F.⁷,Lips D.⁸,van Grevenstein W. M. U.⁹,Karsten T. M.¹⁰,Lange J. F.¹,D'Hoore A.¹¹,Wolthuis A. M.¹¹^ORCID

Affiliation:

1. Department of Surgery Erasmus University Medical Center Rotterdam The Netherlands

2. Department of Surgery University Hospital Antwerp Edegem Belgium

3. Department of Biostatistics Erasmus University Medical Center Rotterdam The Netherlands

4. Department of Surgery Isala Zwolle The Netherlands

5. Department of Surgery IJsselland Ziekenhuis Capelle aan den IJssel The Netherlands

6. Department of Surgery Reinier de Graaf Gasthuis Delft The Netherlands

7. Department of Surgery VU University Medical Center Amsterdam The Netherlands

8. Department of Surgery Jeroen Bosch Ziekenhuis Hertogenbosch The Netherlands

9. Department of Surgery Universitair Medisch Centrum Utrecht Utrecht The Netherlands

10. Department of Surgery Onze Lieve Vrouwe Gasthuis Amsterdam The Netherlands

11. Departmenf of Abdominal Surgery University Hospital Leuven Leuven Belgium

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/codi.14601

Reference32 articles.

1. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands

2. A National Strategic Change in Treatment Policy for Rectal Cancer—Implementation of Total Mesorectal Excision as Routine Treatment in Norway. A National Audit

3. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial

4. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial

5. A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life and functional outcomes after laparoscopic total mesorectal excision (LaTME) and transanal total mesorectal excision (taTME) for rectal cancer. an updated meta-analysis;International Journal of Colorectal Disease;2024-08-09

2. The role of transanal compared to laparoscopic total mesorectal excision (taTME vs. lapTME) for the treatment of mid-low rectal cancer in obese patients: outcomes of a multicenter propensity-matched analysis;Updates in Surgery;2023-10-31

3. Comparing perioperative and oncological outcomes of transanal and laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of randomized controlled trials and prospective studies;Surgical Endoscopy;2023-10-23

4. Total Mesorectal Excision for Rectal Cancer: Top Down or Bottom Up?;Difficult Decisions in Surgery: An Evidence-Based Approach;2023

5. Pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of 26 studies;International Journal of Colorectal Disease;2022-04-11